.png)
Crossing borders with real-world evidence: lessons from the elacestrant case
Webinar: An HEOR playbook for oncology RWE and AI use to support European HTA
What we’ve learned from the first EU joint clinical assessments: Takeaways from a panel of RWE and HTA experts
One Standard, Many Markets: What FDA, EMA, and PMDA Actually Agree On
.png)
ASCO 2026: Translating oncology innovation into real-world impact
Rewriting the real-world evidence playbook for clinical development
ISPOR 2026 reflections: AI, access, and the evolving role of RWE in oncology
